(3-015) Evaluation of 2021 Standardized Antimicrobial Administration Ratios for Broad-Spectrum and Gram-Positive Antimicrobials with Nationwide Rates of Healthcare Associated MRSA and Multidrug Resistant Pseudomonas Aeruginosa
Monday, December 9, 2024
12:00 PM – 1:00 PM
Location: Hall G, Lower Level
Category: Evaluative Study Topic: Infectious Diseases/HIV